EBGLYSS 250 mg/2mL Injection, Solution
Also known as Lebrikizumab-Lbkz. Coverage in Idaho and Utah (CMS PDP Region 31).
1 of 10 stand-alone Part D plans in Idaho and Utah cover this drug on tier 5.
1 of 1 plans apply a prior authorization, step therapy or quantity limit.
27 Medicare Advantage plans in ID, UT do cover it
Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. ID: 14 plans · UT: 13 plans.
Every plan that covers it
| Plan | Tier | 30-day preferred | 90-day mail | Unit cost | Est. 30-day fill | Restrictions |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP)$132.60/mo premium · $130.00 deductible | 5Specialty Tier | 31% | — | $1911.7352 | — |
|
Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.